Claims for Patent: 8,114,598

Summary for Patent: 8,114,598

Title:	High-sensitivity assays for pathogen detection using metal enhanced fluorescence
Abstract:	The present invention relates to an assay including a surface having silver colloids or islands attached thereto. Attached to the surface and/or silver colloids/islands are polynucleotides which are complimentary to a target polynucleotide sequence. The assay is performed by adding the target polynucleotide sequence to the assay surface and allowed to hybridize with the capture polynucleotides. Fluorophore-labeled capture polynucleotides are added and hybridize to the target polynucleotide. Bound target polynucleotides are detected by metal enhanced fluorescence.
Inventor(s):	Geddes; Chris D. (Bel-Air, MD), Lakowitz; Joseph R. (Ellicott City, MD), Baillie; Leslie W. J. (Columbia, MD)
Assignee:	University of Maryland, Baltimore County (Baltimore, MD)
Application Number:	10/536,502
Patent Claims:	1. A method for detecting a Bacillus anthracis in a sample, the method comprising: a) providing a system consisting of: a layer of immobilized metal particles positioned on a surface substrate, wherein the immobilized metal particles have attached thereto a captured nucleotide sequence probe which is complementary to a known first nucleotide sequence section of a specific single nucleotide sequence of the Bacillus anthracis, wherein each capture nucleotide sequence probe is the same; and a free nucleotide sequence probe, wherein each free nucleotide sequence probe is the same, wherein the free nucleotide sequence probe is complementary to a known second nucleotide sequence section of the specific single nucleotide sequence of B. anthracis and has attached thereto a fluorophore, wherein the fluorophore is incorporated at a specific location on the free nucleotide sequence probe so that binding of the free nucleotide sequence probe to the known second nucleotide sequence section of the B. anthracis causes the fluorophore to be positioned from about 50 to about 500 .ANG. from the surface of the immobilized metal particles; b) contacting the sample with the captured nucleotide sequence probe, wherein any B. anthracis in the sample having a nucleotide sequence complementary to the captured nucleotide sequence probe binds to the captured nucleotide sequence probe; and c) contacting any bound B. anthracis sequence with the free nucleotide sequence probe, thereby positioning the fluorophore for enhancing fluorescence emission when excited by an irradiating source and using such emissions to detect the presence of B. anthracis. 2. The method according to claim 1, wherein the metal particles are silver or gold. 3. The method according to claim 1, further comprising detecting fluorescence emissions with a detection device. 4. The method according to claim 3, wherein the detection device comprises a spectrometer, luminometer, plate reader, fluorescent scanner, or flow cytometer. 5. The method according to claim 1, wherein the captured nucleotide sequence probe is covalently linked to the immobilized metal particles. 6. The method according to claim 1, wherein binding of the captured and free nucleotide sequence probes to the first and second known nucleotide sequences of B. anthracis is conducted under highly stringent hybridization conditions. 7. The method according to claim 1, wherein the irradiating source uses a 1-photon or 2-photon excitation means. 8. The method according to claim 1, wherein the fluorophore comprises a low quantum yield species. 9. The method according to claim 1, wherein the fluorophore can undergo two-photon excitation. 10. The method according to claim 1, wherein the fluorophore is Rhodamine B, rose bengal or fluorescein isothiocyanate. 11. The method according to claim 1, wherein the free nucleotide sequence probe further comprises a metal colloid attached thereto and positioned for sandwiching the fluorophore between the metal colloid and the immobilized metal particles on the substrate when the known second nucleotide sequence of B. anthracis is bound. 12. An assay method for detecting a target pathogen in a sample, the method comprising: a) providing a system consisting of: an immobilized metallized layer positioned on a surface substrate, wherein the immobilized metallized layer has attached thereto an immobilized capture nucleotide sequence probe complementary to a first known nucleotide sequence of a specific single nucleotide sequence of the target pathogen, wherein each immobilized capture nucleotide sequence probe is the same having a specific length and sequence of nucleotides; a free nucleotide sequence probe, wherein each free nucleotide sequence probe is the same having a specific length and sequence of nucleotides, wherein the free nucleotide sequence probe is complementary to a second known nucleotide sequence of the specific single nucleotide sequence of the target pathogen, wherein the free nucleotide sequence probe has attached thereto a fluorophore, wherein the fluorophore is incorporated at a specific location on the free nucleotide sequence probe so that binding of the free nucleotide sequence probe to the nucleotide sequence of the target pathogen causes the fluorophore to be positioned from about 50 to about 500 .ANG. from the immobilized metallized surface; b) contacting the sample with the immobilized capture nucleotide sequence probe, wherein the nucleotide sequence of the target pathogen binds to the immobilized capture nucleotide sequence probe; and c) contacting the bound nucleotide sequence of the target pathogen with the free nucleotide sequence probe; and d) identifying the target pathogen by fluorescence emission by irradiating the system with an irradiating source to excite the fluorophore. 13. The method according to claim 12, wherein the target pathogen is B. anthracis. 14. The method according to claim 12, wherein the metallized surface comprises metal particles comprising silver or gold. 15. The method according to claim 12, further comprising detecting fluorescence emission with a detection device. 16. The method according to claim 15, wherein the detection device comprises a spectrometer, luminometer, plate reader, fluorescent scanner, or flow cytometer. 17. The method according to claim 12, wherein the irradiating source uses a 1-photon or 2-photon excitation means. 18. The method according to claim 12, wherein the fluorophore comprises a low quantum yield species. 19. The method according to claim 12, wherein the fluorophore can undergo two-photon excitation. 20. The method according to claim 12, wherein the fluorophore is Rhodamine B, rose bengal or fluorescein isothiocyanate. 21. The method according to claim 12, wherein the free nucleotide sequence probe further comprises a metal colloid attached thereto and positioned for sandwiching the fluorophore between the metal colloid and immobilized metal particles on the surface substrate when the nucleotide sequence of the target pathogen is bound to the immobilized metal particles.

Details for Patent 8,114,598

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Emergent Biodefense Operations Lansing Llc	BIOTHRAX	anthrax vaccine adsorbed	Injection	103821	11/12/1998		2022-11-26